Science Explorer Back to mapMap
Discussion
Company · Reutlingen · Germany

TETEC Tissue Engineering Technologies (Germany)

tetec-ag.comROR OpenAlex
Research works
11
▲ 12% vs 2018-21
Citations
282
24.9 per fractional work
Top-10% rate
7.2%
all institutions 10.0%
Open access
60%
world 40%
International
48%
world 18%
TETEC Tissue Engineering Technologies (Germany)

Not ranked overall: TETEC Tissue Engineering Technologies (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does TETEC Tissue Engineering Technologies (Germany) work in?

In all years, 68% of research at TETEC Tissue Engineering Technologies (Germany) is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (12%), Economics, Econometrics and Finance (9%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 68.4% of its workMedicine: 7 fractional works · 64.4% of its workRheumatology: 2 fractional works · 13.8% of its workSurgery: 2 fractional works · 13.5% of its workPathology and Forensic Medicine: 1 fractional works · 9.4% of its workGenetics: 1 fractional works · 4.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 4.3% of its workPharmacology: 0 fractional works · 4.1% of its workUrology: 0 fractional works · 3.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.3% of its workOncology: 0 fractional works · 2.9% of its workPhysiology: 0 fractional works · 2.9% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 2.5% of its workSmall Animals: 0 fractional works · 2.5% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.5% of its workLife Sciences: 2 fractional works · 15.7% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 11.7% of its workMolecular Biology: 1 fractional works · 4.5% of its workCell Biology: 0 fractional works · 3.9% of its workAging: 0 fractional works · 1.5% of its workMolecular Medicine: 0 fractional works · 1.5% of its workCancer Research: 0 fractional works · 0.4% of its workImmunology and Microbiology: 0 fractional works · 2.5% of its workImmunology: 0 fractional works · 2.5% of its workNeuroscience: 0 fractional works · 1.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.5% of its workSocial Sciences: 1 fractional works · 8.8% of its workEconomics, Econometrics and Finance: 1 fractional works · 8.8% of its workEconomics and Econometrics: 1 fractional works · 8.8% of its workPhysical Sciences: 1 fractional works · 7.1% of its workEngineering: 1 fractional works · 4.9% of its workBiomedical Engineering: 0 fractional works · 2.9% of its workAutomotive Engineering: 0 fractional works · 1.0% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 1.0% of its workComputer Science: 0 fractional works · 1.0% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.0% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workRadiation: 0 fractional works · 0.6% of its workALL ITS WORKTETEC TissueEngineering…11fractional works, all years
Life Sciences16%Physical Sciences7%Health Sciences68%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine764.4%
    2. Veterinary02.5%
    3. Health Professions01.5%
    1. Biochemistry, Genetics and Molecular Biology111.7%
    2. Immunology and Microbiology02.5%
    3. Neuroscience01.5%
    1. Economics, Econometrics and Finance18.8%
    1. Engineering14.9%
    2. Computer Science01.0%
    3. Materials Science00.6%
    4. Physics and Astronomy00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.25× its world share, 0 worksBiochemistry, Geneti…Computer Science: 0.47× its world share, 0 worksComputer ScienceEngineering: 0.81× its world share, 0 worksEngineeringMaterials Science: 0.62× its world share, 0 worksMaterials ScienceHealth Professions: 2.06× its world share, 0 worksHealth ProfessionsMedicine: 3.35× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 5.08× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.1×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Economics, Econometrics and Finance5.08×0 works
  2. Medicine3.35×2 works
  3. Health Professions2.06×0 works
  4. Engineering0.81×0 works
  5. Materials Science0.62×0 works
  6. Computer Science0.47×0 works
  7. Biochemistry, Genetics and Molecular Biology0.25×0 works

What are the most cited papers from TETEC Tissue Engineering Technologies (Germany)?

The most cited paper from TETEC Tissue Engineering Technologies (Germany) is "Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology" (Alwin Scharstuhl, Bernhard Schewe, Karin Benz et al., 2007), with 198 citations. Next come "Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads" (196) and "Human Anulus Fibrosis and Nucleus Pulposus Cells of the Intervertebral Disc" (131).

Most cited papers
#PaperReleasedCitations
1 Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology Alwin Scharstuhl, Bernhard Schewe, Karin Benz et al. · Stem Cells 13 Sep 2007 198
2 Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads Tatiana Gründer, Christoph Gaissmaier, Jürgen Fritz et al. · Osteoarthritis and Cartilage Open access 17 Jun 2004 196
3 Human Anulus Fibrosis and Nucleus Pulposus Cells of the Intervertebral Disc Torsten Kluba, Thomas Niemeyer, Christoph Gaissmaier et al. · Spine Dec 2005 131
4 Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine Mareike Florek, Nicola Bauer, Peggy Janich et al. · Cell and Tissue Research 15 Nov 2006 75
5 Hypoxic Conditions during Expansion Culture Prime Human Mesenchymal Stromal Precursor Cells for Chondrogenic Differentiation in Three-Dimensional Cultures Jana Annina Müller, Karin Benz, Michael J. Ahlers et al. · Cell Transplantation Open access Nov 2011 61
All 37 most cited papers, with filters and sorting

Which research topics does TETEC Tissue Engineering Technologies (Germany) publish most on?

By volume in 2022-now: Osteoarthritis Treatment and Mechanisms, Radiomics and Machine Learning in Medical Imaging, Musculoskeletal pain and rehabilitation and Spine and Intervertebral Disc Pathology.

Osteoarthritis Treatment…0Osteoarthritis Treatment and Mechanisms: 0 fractional worksRadiomics and Machine Le…0Radiomics and Machine Learning in Medical Imaging: 0 fractional worksMusculoskeletal pain and…0Musculoskeletal pain and rehabilitation: 0 fractional worksSpine and Intervertebral…0Spine and Intervertebral Disc Pathology: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksShoulder Injury and Treatment: 0 fractional worksHealthcare Systems and P…0Healthcare Systems and Practices: 0 fractional worksPharmaceutical Economics…0Pharmaceutical Economics and Policy: 0 fractional worksTotal Knee Arthroplasty …0Total Knee Arthroplasty Outcomes: 0 fractional worksAutonomous Vehicle Techn…0Autonomous Vehicle Technology and Safety: 0 fractional works
RheumatologyRadiology, Nuclear Medicine and ImagingPharmacologyPathology and Forensic Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  2. 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Musculoskeletal pain and rehabilitation Pharmacology 0 works
  4. 4 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Shoulder Injury and Treatment Surgery 0 works
  7. 7 Healthcare Systems and Practices General Health Professions 0 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  9. 9 Total Knee Arthroplasty Outcomes Surgery 0 works
  10. 10 Autonomous Vehicle Technology and Safety Automotive Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.6%not open40.4%

World: 40% of research is openly available.

with international co-authors48.1%domestic only51.9%

World: 18% is written across borders.

How has TETEC Tissue Engineering Technologies (Germany)'s research output changed?

Output in 2022-2025 was 12% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is TETEC Tissue Engineering Technologies (Germany) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.000020%0.000040%0.000060%TETEC Tissue Engineering Technologies (Germany)0.0000034% in 202520102020

Fractional works of TETEC Tissue Engineering Technologies (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Reutlingen

All research institutions in Reutlingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about TETEC Tissue Engineering Technologies (Germany). Posts are plain text and can be reported.